Fine-needle aspiration biopsy of hurthle cell lesions of the thyroid gland: A cytomorphologic study of 139 cases with statistical analysis

Cancer

Volumn 108, Issue 2, 2006, Pages 102-109

  Elliott, Danielle D ^a   Pitman, Martha B ^b   Bloom, Leonard ^c   Faquin, William C ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Fine needle aspiration; Hurthle cell; Neoplasm; Statistical; Thyroid

Indexed keywords

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; CANCER CYTODIAGNOSIS; FEMALE; HUMAN; HUMAN CELL; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; ONCOCYTOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THYROID ADENOMA; THYROID CARCINOMA; THYROID DISEASE; THYROID NODULE; THYROID PARAFOLLICULAR CELL;

ADENOMA; ADENOMA, OXYPHILIC; ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; CELL NUCLEUS; COLLOIDS; CYTOPLASM; DATA INTERPRETATION, STATISTICAL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LOGISTIC MODELS; MALE; METAPLASIA; MIDDLE AGED; OXYPHIL CELLS; THYROID GLAND; THYROID NEOPLASMS;

EID: 33645974572     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.21716     Document Type: Article

References (24)

1. Hoos A, Stojadinovic A, Singh B, et al. Clinical significance of molecular expression profiles of Hurthle cell tumors of the thyroid gland analyzed via tissue microarrays. Am J Pathol. 2002;160:175-183.
2. Chiappetta G, Toti P, Cetta F, et al. The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions. J Clin Endocrinol Metab. 2002;87:364-369.
3. Tyler DS, Winchester DJ, Caraway NP, Hickey RC, Evans DB. Indeterminate fine-needle aspiration biopsy of the thyroid: identification of subgroups at high risk for invasive carcinoma. Surgery. 1994;116:1054-1060.
4. Tuttle RM, Lemar H, Burch HB. Clinical features associated with an increased risk of thyroid malignancy in patients with follicular neoplasia by fine-needle aspiration. Thyroid. 1998; 8:377-383.
5. Schlinkert RT, van Heerden JA, Goellner JR, et al. Factors that predict malignant thyroid lesions when fine-needle aspiration is "suspicious for follicular neoplasm." Mayo Clin Proc. 1997;72:913-916.
6. Giorgadze T, Rossi ED, Fadda G, Gupta PK, Livolsi VA, Baloch Z. Does the fine-needle aspiration diagnosis of "Hurthle-cell neoplasm/follicular neoplasm with oncocytic features" denote increased risk of malignancy? Diagn Cytopathol. 2004;31:307-312.
7. Chen H, Nicol TL, Zeiger MA, et al. Hurthle cell neoplasms of the thyroid: are there factors predictive of malignancy? Ann Surg. 1998;227:542-546.
8. McHenry CR, Thomas SR, Slusarczyk SJ, Khiyami A. Follicular or Hurthle cell neoplasm of the thyroid: can clinical factors be used to predict carcinoma and determine extent of thyroidectomy? Surgery. 1999;126:798-802.
9. Bondeson L, Bondeson AG, Lindholm K, Ljungberg O, Tibblin S. Morphometric studies on nuclei in smears of fine needle aspirates from oxyphilic tumors of the thyroid. Acta Cytol. 1983;27:437-440.
10. Bonilla AJ, Caudill JL, Goellner JR. Neoplastic versus non-neoplastic Hurthle cell lesions: the diagnostic role of transgressing vessels and intracytoplasmic inclusions [abstract]. Acta Cytol. 1999;43:951.
11. Gonzalez JL, Wang HH, Ducatman BS. Fine-needle aspiration of Hurthle cell lesions. A cytomorphologic approach to diagnosis. Am J Clin Pathol. 1993;100:231-235.
12. Jayaram G. Problems in the interpretation of Hurthle cell populations in fine needle aspirates from the thyroid. Acta Cytol. 1983;27:84-85.
13. Kini SR, Miller JM, Hamburger JI. Cytopathology of Hurthle cell lesions of the thyroid gland by fine needle aspiration. Acta Cytol. 1981;25:647-652.
14. Nguyen GK, Husain M, Akin MR. Cytodiagnosis of benign and malignant Hurthle cell lesions of the thyroid by fine-needle aspiration biopsy. Diagn Cytopathol. 1999;20:261-265.
15. Pambuccian SE, Becker RL Jr., Ali SZ, Savik K, Rosenthal DL. Differential diagnosis of Hurthle cell neoplasms on fine needle aspirates. Can we do any better with morphometry? Acta Cytol. 1997;41:197-208.
16. Ravinsky E, Safneck JR. Differentiation of Hashimoto's thyroiditis from thyroid neoplasms in fine needle aspirates. Acta Cytol. 1988;32:854-861.
17. Silver SA, Busseniers AE. Cytologic criteria for differentiating neoplastic from nonneoplastic Hurthle cell lesions by fine-needle aspiration [abstract]. In: Abstracts of the United States and Canadian Academy of Pathology, 1995:242.
18. Vodanovic S, Crepinko I, Smoje J. Morphologic diagnosis of Hurthle cell tumors of the thyroid gland. Acta Cytol. 1993; 37:317-322.
19. Yang YJ, Khurana KK. Diagnostic utility of intracytoplasmic lumen and transgressing vessels in evaluation of Hurthle cell lesions by fine-needle aspiration. Arch Pathol Lab Med. 2001;125:1031-1035.
20. Nguyen GK, Ginsberg J, Crockford PM, Villanueva RR. Hashimoto's thyroiditis: cytodiagnostic accuracy and pitfalls. Diagn Cytopathol. 1997;16:531-536.
21. Renshaw AA. Hurthle cell carcinoma is a better gold standard than Hurthle cell neoplasm for fine-needle aspiration of the thyroid: defining more consistent and specific cytologic criteria. Cancer (Cancer Cytopathol). 2002;96:261-266.
22. Gharib H, Goellner JR, Johnson DA. Fine-needle aspiration cytology of the thyroid. A 12-year experience with 11,000 biopsies. Clin Lab Med. 1993;13:699-709.
23. Gonzalez-Campora R, Herrero-Zapatero A, Lerma E, Sanchez F, Galera H. Hurthle cell and mitochondrion-rich cell tumors. A clinicopathologic study. Cancer. 1986;57:1154-1163.
24. DeLellis R, Lloyd R, Heitz P, Eng C. Pathology and genetics of tumors of endocrine organs. World Health Organization classification of tumours. Lyon: IARC Press, 2004.